← Open Payments lookup

MELANIE MALONE: Open Payments

NPI 1851473102 · RUSSELLVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,889 in 108 payments from 18 companies in 2025. Trend: 2023 $1,922 · 2024 $2,021 · 2025 $1,889

Food & beverage: $1,889
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$370
ABBVIE INC.38$355
Novo Nordisk Inc10$263
Lilly USA, LLC11$175
AstraZeneca Pharmaceuticals LP4$163
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$104
PFIZER INC.5$97
Phathom Pharmaceuticals, Inc.3$69
Amgen Inc.4$63
Boehringer Ingelheim Pharmaceuticals, Inc.4$57

Products named: CAPLYTA, Ozempic, VRAYLAR, FARXIGA, XIFAXAN, QULIPTA, MOUNJARO, UBRELVY.

Industry payments across AL — which companies pay providers there.